![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Parkinson's Disease |
Free Subscription
1 BMC Neurol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Parkinson's Disease is free of charge.
Recognition of freezing of gait in Parkinson's disease based on combined wearable
sensors.
BMC Neurol. 2022;22:229.
PubMed
Abstract available
Spectral and spatial distribution of subthalamic beta peak activity in
Parkinson's disease patients.
Exp Neurol. 2022 Jun 19:114150. doi: 10.1016/j.expneurol.2022.114150.
PubMed
Abstract available
Cognitive deficits and altered cholinergic innervation in young adult male mice
carrying a Parkinson's disease Lrrk2(G2019S) knockin mutation.
Exp Neurol. 2022 Jun 19:114145. doi: 10.1016/j.expneurol.2022.114145.
PubMed
Abstract available
Efficacy and safety of apomorphine pump infusion in Filipino patients
insufficiently controlled on oral anti-Parkinson medications: an open-label,
pilot study.
Int J Neurosci. 2022 Jun 20:1-10. doi: 10.1080/00207454.2022.2090352.
PubMed
Abstract available
Morphological basis of Parkinson disease-associated cognitive impairment: an
update.
J Neural Transm (Vienna). 2022 Jun 20. pii: 10.1007/s00702-022-02522.
PubMed
Abstract available
Essential tremor plus rest tremor: current concepts and controversies.
J Neural Transm (Vienna). 2022;129:835-846.
PubMed
Abstract available
Genetics of validated Parkinson's disease subtypes in the Oxford Discovery and
Tracking Parkinson's cohorts.
J Neurol Neurosurg Psychiatry. 2022 Jun 22. pii: jnnp-2021-327376.
PubMed
Abstract available
A 10-Year Community-Based Study of Leucine-Rich Repeat Kinase 2 G2385R Carriers'
Conversion to Parkinson's Disease.
Mov Disord. 2022 Jun 22. doi: 10.1002/mds.29127.
PubMed
Abstract available
Neurodevelopmental Gene-Related Dystonia-Parkinsonism with Onset in Adults: A
Case with NAA15 Variant.
Mov Disord. 2022 Jun 22. doi: 10.1002/mds.29125.
PubMed
Bacterial Butyrate in Parkinson's Disease Is Linked to Epigenetic Changes and
Depressive Symptoms.
Mov Disord. 2022 Jun 20. doi: 10.1002/mds.29128.
PubMed
Abstract available
Resolving Missing Data from the Movement Disorder Society Unified Parkinson's
Disease Rating Scale: Implications for Telemedicine.
Mov Disord. 2022 Jun 18. doi: 10.1002/mds.29129.
PubMed
Abstract available
Functional Analyses of Two Novel LRRK2 Pathogenic Variants in Familial
Parkinson's Disease.
Mov Disord. 2022 Jun 16. doi: 10.1002/mds.29124.
PubMed
Abstract available
Reply to: "Risk Disclosure in Prodromal Parkinson's Disease".
Mov Disord. 2022;37:1327.
PubMed
Disordered Decision Making: A Cognitive Framework for Apathy and Impulsivity in
Huntington's Disease.
Mov Disord. 2022;37:1149-1163.
PubMed
Abstract available
Understanding the contributions of VPS35 and the retromer in neurodegenerative
disease.
Neurobiol Dis. 2022;170:105768.
PubMed
Abstract available
Age-dependent neurodegeneration and neuroinflammation in a genetic A30P/A53T
double-mutated alpha-synuclein mouse model of Parkinson's disease.
Neurobiol Dis. 2022 Jun 21:105798. doi: 10.1016/j.nbd.2022.105798.
PubMed
Abstract available
Asleep DBS under ketamine sedation: Proof of concept.
Neurobiol Dis. 2022;170:105747.
PubMed
Abstract available
Neuroprotection by Mucuna pruriens in Neurodegenerative Diseases.
Neurochem Res. 2022;47:1816-1829.
PubMed
Abstract available
Inhaled Levodopa (CVT-301) for the Treatment of Parkinson Disease: A Systematic
Review and Meta-analysis of Randomized Controlled Trials.
Neurol Clin Pract. 2022;12:139-148.
PubMed
Abstract available
Genome Sequencing in the Parkinson Disease Clinic.
Neurol Genet. 2022;8:e200002.
PubMed
Abstract available
Pharmacokinetics of Intravenously (DIZ101), Subcutaneously (DIZ102), and
Intestinally (LCIG) Infused Levodopa in Advanced Parkinson Disease.
Neurology. 2022 Jun 15. pii: WNL.0000000000200804.
PubMed
Abstract available
Physical inactivity links depressive symptoms and cognitive functioning among
individuals with Parkinson's disease.
Neuropsychology. 2022 Jun 23. pii: 2022-74636-001. doi: 10.1037/neu0000837.
PubMed
Abstract available
N-cystaminylbiguanide MC001 prevents neuron cell death and alleviates motor
deficits in the MPTP-model of Parkinson's disease.
Neurosci Lett. 2022 Jun 20:136751. doi: 10.1016/j.neulet.2022.136751.
PubMed
Abstract available
Role of CD36 rs1761667 AA genotype in the expression of inflammatory cytokines
and Parkinson's disease progression: A case-control study in a northern Han
Chinese population.
Neurosci Lett. 2022;784:136736.
PubMed
Abstract available
Insulin-like growth factor in Parkinson's disease is related to nonmotor symptoms
and the volume of specific brain areas.
Neurosci Lett. 2022;783:136735.
PubMed
Abstract available
Association between ABCA7 gene polymorphisms and Parkinson's disease
susceptibility in a northern Chinese Han population.
Neurosci Lett. 2022;784:136734.
PubMed
Abstract available
Model-based quantitative optimization of deep brain stimulation and prediction of
parkinson's states.
Neuroscience. 2022 Jun 21. pii: S0306-4522(22)00255.
PubMed
Abstract available
Predictors of rapid eye movement sleep behavior disorder in patients with
Parkinson's disease based on random forest and decision tree.
PLoS One. 2022;17:e0269392.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by